The reported gadolinium deposition phenomenon has caused extensive concern in the radiology community. This study focuses on validating the clinical performance of a proposed deep learning architecture which can significantly reduce the dosage of gadolinium-based contrast agents (GBCA) in brain MRI. The results suggest that the synthesized contrast images using deep learning with reduced GBCA dose can maintain its diagnostic quality under certain clinical circumstances.
This abstract and the presentation materials are available to members only; a login is required.